Current legal access pathways are: Licensed 503A compounding pharmacy: Compounds to an individual patient prescription
The antidepressant classes, selective serotonin reuptake inhibitors (SSRI), serotonin and noradrenalin reuptake inhibitors (SNRI), tricyclic antidepressants (TCA), monoamine oxidase inhibitors (MAOI), and atypical antidepressants that increase neurotransmitters serotonin, noradrenaline, and dopamine are in the guideline-based treatment strategies of depression [144]
Advances in Gerontology 5(4):228-234. [doi.org]
But peptides are not the only factor in improving growth hormone levels
As research progresses, it is expected that more refined dosing protocols and additional combination options will emerge, further enhancing the ability to tailor treatment to individual needs
Epigenetical targeting of the FOXP3 gene by S-adenosylmethionine diminishes the suppressive capacity of regulatory T cells ex vivo and alters the expression profiles